It is our policy to provide patients, physicians and others with information about Bristol-Myers Squibb sponsored clinical trials that are conducted on investigational compounds and marketed products. We publicly disclose study information on Bristol-Myers Squibb sponsored interventional trials, as well as certain non-interventional clinical trials.
Registration of clinical trials
Bristol-Myers Squibb sponsored trials are those studies in which our company is ultimately responsible for all aspects of the study, even if some or all of these activities are transferred to another party. Bristol-Myers Squibb will register all Bristol-Myers Squibb sponsored Phase I, II, III and IV interventional trials on www.clinicaltrials.gov and other applicable websites as required. For specific trials where Bristol-Myers Squibb is not the sponsor, but has agreed to carry out the disclosure responsibility of the sponsor, Bristol-Myers Squibb will register the trials.
Disclosure of clinical trials
Our policy also calls for the open and timely reporting of results from Bristol-Myers Squibb sponsored clinical trials involving Bristol-Myers Squibb marketed products. Bristol-Myers Squibb shares clinical trials results through scientific congresses or publication in peer-reviewed journals. In addition, results for clinical trials completed after 2008 on marketed products are available at www.ClinicalTrials.gov. Our goal is to present these clinical trial results in an accurate, balanced and complete manner regardless of development phase or outcome. Results will not be posted on www.ClinicalTrials.gov for new formulations of marketed products until the new formulation is approved by a regulatory agency unless the trial data is clinically relevant to the use of the marketed product. In general, results from non-Bristol-Myers Squibb sponsored trials will not be reported by Bristol-Myers Squibb. However, for certain trials where Bristol-Myers Squibb is not the sponsor but has agreed to carry out the disclosure responsibility of the sponsor, Bristol-Myers Squibb will post the results as required.
Date of preparation: May 2018; MLTUK1701479-01